Overview

Quality deficiencies in the drug supply chain, sometimes resulting in large-scale drug recalls, have captured headlines in the US in recent years. 

But are the quality issues featured in the media widespread, or are they unfortunate one-off events driven by bad actors in the system?

The 2021 Pharmaceutical Outcomes and Policy Seminar will examine the complex and interrelated scientific, regulatory, supply chain, and system factors that underpin drug supply and utilization in the US. Experts will explain the challenges they face in ensuring that patients have access to pharmaceutical products that are safe and effective and of high quality. Participants will consider the implications of potential erosion in generic drug utilization on patient outcomes and costs. Finally, industry leaders will pose regulatory, delivery, and commercial solutions to improve the quality of the drug supply chain.

Logistics

Location: Seminar will take place via Zoom
Dates: Saturday, March 6 & Sunday, March 7, 2021 | 11am – 4pm Eastern